Literature DB >> 24142202

The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users.

Simon N Young1, Martine Regoli, Marco Leyton, Robert O Pihl, Chawki Benkelfat.   

Abstract

RATIONALE: Several studies suggest users of 3,4-methylenedioxymethamphetamine (ecstasy) have low levels of serotonin. Low serotonin may make them susceptible to lowered mood.
OBJECTIVE: This work aims to study the acute effects on mood and impulsivity of lowering serotonin levels with acute tryptophan depletion in polydrug ecstasy users and to determine whether effects were different in men and women.
METHODS: In a double-blind cross-over study, participants who had used ecstasy at least 25 times (n = 13) and nonuser controls (n = 17) received a tryptophan-deficient amino acid mixture and a control amino acid mixture containing tryptophan, at least 1 week apart. Mood was measured using the profile of mood states, and impulsivity was measured with the Go/No-Go task.
RESULTS: The main result shows that a lowering of mood after acute tryptophan depletion occurred only in female polydrug ecstasy users (n = 7), relative to controls (n = 9). Results from the Go/No-Go task suggested that impulsivity was not increased by acute tryptophan depletion in polydrug ecstasy users. LIMITATION: The group sizes were small, when males and females were considered separately.
CONCLUSIONS: Women polydrug ecstasy users appear to be more susceptible than men to the effects of lowered serotonin levels. If use of ecstasy alone or in conjunction with other drugs causes progressive damage of serotonin neurons, women polydrug ecstasy users may become susceptible to clinical depression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142202     DOI: 10.1007/s00213-013-3287-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

1.  The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects.

Authors:  A J Cleare; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

2.  Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.

Authors:  Anja C Huizink; Robert F Ferdinand; Jan van der Ende; Frank C Verhulst
Journal:  BMJ       Date:  2006-02-24

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder?

Authors:  A Neumeister; A Habeler; N Praschak-Rieder; M Willeit; S Kasper
Journal:  Int Clin Psychopharmacol       Date:  1999-09       Impact factor: 1.659

5.  Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes.

Authors:  F A Moreno; G R Heninger; C A McGahuey; P L Delgado
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

6.  Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.

Authors:  Suzanne L Verheyden; Joanne Hadfield; Tara Calin; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2002-03-06       Impact factor: 4.530

Review 7.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.

Authors:  G A Ricaurte; J Yuan; U D McCann
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

8.  Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males.

Authors:  D G LeMarquand; R O Pihl; S N Young; R E Tremblay; J R Séguin; R M Palmour; C Benkelfat
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

9.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.

Authors:  Maartje M L de Win; Gerry Jager; Jan Booij; Liesbeth Reneman; Thelma Schilt; Cristina Lavini; Sílvia D Olabarriaga; Gerard J den Heeten; Wim van den Brink
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

View more
  2 in total

1.  Sex-based changes in rat brain serotonin and behavior in a model of altitude-related vulnerability to treatment-resistant depression.

Authors:  Shami Kanekar; Chandni Sheth; Hendrick Ombach; Jadeda Brown; Michael Hoffman; Robert Ettaro; Perry Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2021-06-22       Impact factor: 4.530

2.  The Association between Baseline Subjective Anxiety Rating and Changes in Cardiac Autonomic Nervous Activity in Response to Tryptophan Depletion in Healthy Volunteers.

Authors:  Chih Yin Hsiao; Hsin Chun Tsai; Mei Hung Chi; Kao Chin Chen; Po See Chen; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.